247 related articles for article (PubMed ID: 20590732)
1. Potential manipulation of endothelial progenitor cells in diabetes and its complications.
Fadini GP; Avogaro A
Diabetes Obes Metab; 2010 Jul; 12(7):570-83. PubMed ID: 20590732
[TBL] [Abstract][Full Text] [Related]
2. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Sorrentino SA; Bahlmann FH; Besler C; Müller M; Schulz S; Kirchhoff N; Doerries C; Horváth T; Limbourg A; Limbourg F; Fliser D; Haller H; Drexler H; Landmesser U
Circulation; 2007 Jul; 116(2):163-73. PubMed ID: 17592079
[TBL] [Abstract][Full Text] [Related]
3. Endothelial progenitor cells in diabetes mellitus.
Menegazzo L; Albiero M; Avogaro A; Fadini GP
Biofactors; 2012; 38(3):194-202. PubMed ID: 22488933
[TBL] [Abstract][Full Text] [Related]
4. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
Cubbon RM; Kahn MB; Wheatcroft SB
Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease.
Zhang Q; Kandic I; Kutryk MJ
Biochem Biophys Res Commun; 2011 Feb; 405(1):42-6. PubMed ID: 21195052
[TBL] [Abstract][Full Text] [Related]
6. Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease.
Sen S; McDonald SP; Coates PT; Bonder CS
Clin Sci (Lond); 2011 Apr; 120(7):263-83. PubMed ID: 21143202
[TBL] [Abstract][Full Text] [Related]
7. Habitual physical activity is associated with endothelial function and endothelial progenitor cells in patients with stable coronary artery disease.
Luk TH; Dai YL; Siu CW; Yiu KH; Chan HT; Fong DY; Lee SW; Li SW; Tam S; Lau CP; Tse HF
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):464-71. PubMed ID: 19587603
[TBL] [Abstract][Full Text] [Related]
8. The promise of EPC-based therapies on vascular dysfunction in diabetes.
Georgescu A; Alexandru N; Constantinescu A; Titorencu I; Popov D
Eur J Pharmacol; 2011 Nov; 669(1-3):1-6. PubMed ID: 21839073
[TBL] [Abstract][Full Text] [Related]
9. Daily intake of thiamine correlates with the circulating level of endothelial progenitor cells and the endothelial function in patients with type II diabetes.
Wong CY; Qiuwaxi J; Chen H; Li SW; Chan HT; Tam S; Shu XO; Lau CP; Kwong YL; Tse HF
Mol Nutr Food Res; 2008 Dec; 52(12):1421-7. PubMed ID: 18925614
[TBL] [Abstract][Full Text] [Related]
10. Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury.
Ii M; Takenaka H; Asai J; Ibusuki K; Mizukami Y; Maruyama K; Yoon YS; Wecker A; Luedemann C; Eaton E; Silver M; Thorne T; Losordo DW
Circ Res; 2006 Mar; 98(5):697-704. PubMed ID: 16484619
[TBL] [Abstract][Full Text] [Related]
11. Endothelial progenitor cells.
Doyle B; Metharom P; Caplice NM
Endothelium; 2006; 13(6):403-10. PubMed ID: 17169772
[TBL] [Abstract][Full Text] [Related]
12. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy.
Fadini GP; Sartore S; Albiero M; Baesso I; Murphy E; Menegolo M; Grego F; Vigili de Kreutzenberg S; Tiengo A; Agostini C; Avogaro A
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2140-6. PubMed ID: 16857948
[TBL] [Abstract][Full Text] [Related]
13. Circulating endothelial progenitor cells in cardiovascular disorders.
Geft D; Schwartzenberg S; George J
Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1115-21. PubMed ID: 18793114
[TBL] [Abstract][Full Text] [Related]
14. [Number and function of circulating endothelial progenitor cell in diabetics with different vascular complications].
Chen LL; Liao YF; Zeng TS; Li YM; Yu F; Li HQ
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1234-9. PubMed ID: 19595175
[TBL] [Abstract][Full Text] [Related]
15. Endothelial progenitor cell dysfunction: mechanisms and therapeutic approaches.
Bauersachs J; Thum T
Eur J Clin Invest; 2007 Aug; 37(8):603-6. PubMed ID: 17635570
[No Abstract] [Full Text] [Related]
16. Decreased mobilization of endothelial progenitor cells contributes to impaired neovascularization in diabetes.
Kang L; Chen Q; Wang L; Gao L; Meng K; Chen J; Ferro A; Xu B
Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):e47-56. PubMed ID: 19558529
[TBL] [Abstract][Full Text] [Related]
17. Significance of endothelial progenitor cells in subjects with diabetes.
Fadini GP; Sartore S; Agostini C; Avogaro A
Diabetes Care; 2007 May; 30(5):1305-13. PubMed ID: 17277037
[No Abstract] [Full Text] [Related]
18. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus.
Wang CH; Ting MK; Verma S; Kuo LT; Yang NI; Hsieh IC; Wang SY; Hung A; Cherng WJ
Am Heart J; 2006 Dec; 152(6):1051.e1-8. PubMed ID: 17161050
[TBL] [Abstract][Full Text] [Related]
19. Endothelial progenitor cells as a new agent contributing to vascular repair.
Miller-Kasprzak E; Jagodziński PP
Arch Immunol Ther Exp (Warsz); 2007; 55(4):247-59. PubMed ID: 17659378
[TBL] [Abstract][Full Text] [Related]
20. Characterization of endothelial progenitor cells in the NOD mouse as a source for cell therapies.
Khoo CP; Valorani MG; Brittan M; Alison MR; Warnes G; Johansson U; Hawa M; Pozzilli P
Diabetes Metab Res Rev; 2009 Jan; 25(1):89-93. PubMed ID: 19065604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
